The Effects of Glucose Fluctuation on the Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus

Table 1

Comparison of the indexes in the three groups.

	Group A	Group B	Group C
Sex (M/F)	24/16	24/32	48/44
Age (years)	56.3±6.1	56.1±6.6	61.7±7.2^*#
BMI (Kg/m^2)	23.8±2.5	27.0±3.6 *	24.5±1.7
CD (year)	—	6.10 (4.54, 8.11)	4.73 (2.77, 7.70)
Antihypertension drug user (%)	4 (10%)	31 (55.4%)**	55 (59.8%)**
SBP (mmHg)	114±13	124±9	136±18^**#
DBP (mmHg)	70 (65–75)	72 (66–79)	80 (80-81)^*#
HbA1c (%)	5.3±0.3	6.6±1.2 **	7.5±1.4^**#
HDL-c (mmol/L)	0.88 (0.83–0.92)	0.96 (0.92–1.27)*	0.91 (0.85–1.13)
LDL-c (mmol/L)	2.16 (2.05–2.20)	2.51 (1.78–2.92)	2.17 (2.07–3.23)
TG (mmol/L)	1.63 (1.58–1.66)	2.12 (1.21–4.11)	1.70 (1.42–2.23)
TC (mmol/L)	4.14 (3.93–4.25)	4.74 (4.05–4.79)	4.11 (3.57–4.46)
GSH (mmol/L)	4.23±0.64	3.18±0.86	2.24±0.73
MBG (mmol/L)	6.1±0.6	8.1±2.1 *	8.0±1.4 **
MAGE (mmol/L)	2.2 (1.8, 2.8)	2.6 (1.9, 3.5)**	4.0 (3.3, 4.8)^**##
NEGE (times)	6.8 (6.0, 7.7)	4.1 (3.5, 4.7)**	4.0 (3.4, 4.8)**
SDBG (mmol/L)	0.8±0.3	1.5±0.4 **	2.0±0.8^**#
LAGE (mmol/L)	2.9 (2.6–4.5)	6.6 (5.8–12.4)**	7.8 (6.1–9.9)**
PPGE1 (mmol/L)	2.7 (1.6–4.3)	3.2 (1.7–9.8)	4.6 (3.2–8.1)**
PPGE2 (mmol/L)	2.3 (1.7–3.5)	2.4 (2.2–8.6)	3.3 (2.6–5.4)*
PPGE3 (mmol/L)	2.2±0.4	2.7±1.1	4.7±2.5^**##
IMT (mm)	0.6±0.1	0.9±0.3 *	1.1±0.3^**#
CRP (mg/L)	1.0 (0.9–1.1)	1.1 (1.0–2.8)*	3.8 (2.8–5.4)^**##
HOMA-IR	1.58 (1.52–1.69)	2.3 (1.9–9.1)**	4.3 (3.0–4.9)**
HBCI	87 (82–103)	45 (28–67)**	80 (48–139)^##
SYNTAX score	—	0	23.5±5.9

CD: course of disease. Compared with group A, *𝑃<0.05, **𝑃<0.01; compared with group B, ^#𝑃<0.05, ^##𝑃<0.01.